Dexamethasone as an Immediate Intervention



Status:Withdrawn
Conditions:Hospital
Therapuetic Areas:Other
Healthy:No
Age Range:18 - 70
Updated:12/16/2017
Start Date:January 2017
End Date:December 12, 2017

Use our guide to learn which trials are right for you!

Dexamethasone as an Immediate Intervention to Reduce Long-Term Stress Responses

To determine if a single dose of dexamethasone (5 mg) administered in the first 12 hours
following a potentially traumatic event alters a) cortisol and FKBP5 RNA the next day in the
periphery measured in saliva; b) FKBP5 methylation by 1 month; c) executive functioning and
emotion regulation functioning; d) psychophysiological (heart rate, respiration, skin
conductance) in response cued reminders of the trauma; e) enhances the likelihood of
remission of PTSD symptom severity.


Inclusion Criteria:

- Adults 18-70 years

- Evidence of acute Post Traumatic Event (PTE) exposure defined by Diagnostic and
Statistical Manual criterion 'A'

- Evidence of a significant stress response defined by DSM V PTSD criterion 'B' and
meeting at least criteria for 'partial PTSD' or a minimum of 3 of 4 DSM V PTSD symptom
criterion

- Score of 60 or higher on the Subjective Units of Distress Scale (SUDS)

- Living in New York tri-state area

- Fluency in English, Spanish

Exclusion Criteria:

- Admission to an intensive care unit or other overnight admission

- In the Emergency Department for more than 6 hours

- Evidence of ongoing traumatic exposure (e.g. domestic violence)

- Evidence of psychotic symptoms

- Evidence of homicidality/suicidality

- Adults with an open head injury, a positive CT scan, loss of consciousness >30 seconds
or survivors in a coma

- Adults in police custody or Department of Correction (DOC) patients

- Inability to understand the study's procedures, risks, or side effects, or otherwise
unable to give informed consent.

- Females who are nursing or pregnant (as confirmed by a positive urine pregnancy test).

- Permanent cardiac pacer implant.

- . Self-reported medical conditions that may be affected by DEX including asthma,
epilepsy,diabetes, liver disease, kidney disease, thyroid disorder, muscle disorder,
history of malaria,tuberculosis, osteoporosis, glaucoma or cataracts.

- Self-reported adverse reactions to steroids
We found this trial at
1
site
New York, New York 10021
?
mi
from
New York, NY
Click here to add this to my saved trials